ACT

MAY 14/2019


Advertisement

news roundup

Clinerion Partners with Czech Clinical Research Institute

Clinerion has announced its partnership with the Czech Clinical Research Institute (CCRI) to bring its services to patients in the Czech Republic and Slovakia.


Advertisement

The Inside Story: How Bristol-Myers Squibb Connects Patients with Clinical Trials
— Live webinar on May 30, 2019
Reserve your spot now


Tufts CSDD Says AI Adoption is High

The Tufts Center for Drug Development found in a recent analysis that the pharmaceutical industry is adopting artificial intelligence (AI) and the highest uses of AI are in clinical operations, safety/risk management, and information technology.


Advertisement

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
North America: Thursday, June 13, 2019 at 11am EDT | 10am CDT | 8am PDT
Register now


CISCRP to Develop Plain Language Summary Template for NCI

The National Cancer Institute's National Clinical Trials Network has chosen the Center for Information and Study on Clinical Research Participation (CISCRP) to lead a project that will result in a template for describing NCI-funded cancer clinical trials actively recruiting patients. The plain language trial summary template for patients will be available to all members in the National Cancer Institute's National Clinical Trials Network.


Advertisement

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
Europe: Thursday, June 6, 2019 at 3pm BST | 4pm CEST
Register now


hyperCORE International "Super Site Network" Launches

hyperCORE International LLP, a super network of eight Clinical Research Site Organizations, has formally launched. The primary goal of the super network is to modernize the highly fragmented and inefficient research site model. They will have more than 80 sites across two continents spanning from Peru to Canada at their launch.


Advertisement

Refocusing on Risk Mitigation in Starting Clinical Trials
Tuesday, May 28, 2019 at 1pm EDT | 12pm CDT | 10am PDT
Register now


Articles

Implementing RWE to Advance Innovative Medicines

Real-World Evidence (RWE) has increasingly become important in oncology where treatment decisions are impacted by the fact that there are many forms of disease and many rare conditions where there is no approved treatment or only conditional approvals.


Advertisement

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
Tuesday, May 21, 2019 at 2:30pm IST | 5pm CST | 6pm JST
Register now


New Medical Device Regulatons in India

This article discusses how new regulations are bringing new and more medical devices to the area.


Advertisement

A new way to assess changes in trial complexity, success and duration: The Clinical Development Productivity Index
Tuesday, May 21, 2019 at 11am EDT
Register now


In this edition

Take this Tufts CSDD Survey on The Vendor Qualification Process!
CISCRP to Develop Plain Language Summary Template for NCI
Re-Imagining Integration for Quality Clinical Trials

Advertisement

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
Wednesday, May 15, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Advertisement

Standardization Drives Transparency and Optimization of Contract/Budget Processes in Clinical Trial Startup
On Demand
Learn More


Events

4th Annual Managed Access Programs and Accelerated Pathways
BIO International Convention
Rare Disease Innovation and Partnering Summit
DIA 2019 Global Annual Meeting
Direct-to-Patient Trials
Search Upcoming Events

Blog Posts

Re-Imagining Integration for Quality Clinical Trials

The level of integration depends on the needs of the trial and the long-term goals of the sponsor. If a sponsor requires an integration for more than one trial, understanding their pipeline enables eClinical technology providers to develop a standardized, repeatable process the sponsor can leverage again and again.


Advertisement

Technology: Friend vs Foe - Considerations for Practical Execution of a Risk-Based Monitoring Strategy
On Demand
Learn More


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
TBaker@mmhgroup.com